- CA$300.17m
- CA$252.95m
- $16.10m
Brief: Profound Medical Q3 EPS USD -0.21
Education Agreement To Advance Psma-Informed Prostate Care
Brief: Profound Medical Announces Management Change
Canada's Profound Medical Q2 loss shrinks on lower costs, revenue hit by shipment timing
Brief: Profound Medical Q2 EPS USD -0.26
Canada Research Roundup: Gibson Energy, Profound Medical, TFI International
Brief: Telix Announces Collaborations To Explore Psma-Pet Imaging In Emerging Prostate Cancer Treatment Approaches
Canada's Profound Medical Q1 revenue more than doubles, beating estimates
Canada's Profound Medical Q4 revenue up 43% but misses estimates
Brief: Profound Medical Q4 EPS USD -0.27
Brief: Profound Medical Announces Closing Of Private Placement
Brief: Profound Medical Closes $36 Million Registered Direct Offering Expects To Complete Subsequent Private Placement On Or Before December 30Th
Brief: Profound Medical Announces $40 Mln Financing with $36 Mln Offering
Brief: Profound Medical Files For Mixed Shelf Offering Of Up To $150 Million - SEC Filing
Profound Medical Q3 revenue beats estimates
Brief: Profound Medical Q3 EPS USD -0.26
Brief: Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO and Sonalleve with Al Faisaliah Medical Systems in Saudi Arabia
Brief: Profound Medical Achieves Record Preliminary Unaudited Revenue For The 2025 Third Quarter
Brief: Profound Medical Q2 EPS USD -0.52